The medicine sector in India presents a challenging landscape, increasingly marked by concerns surrounding concentrated power. While the nation boasts a vibrant generic industry , a few large companies hold a substantial share of the sales, sparking questions about fair practice and patient access to inexpensive medication . This situation is fuele

The pharmaceutical landscape in the nation is increasingly characterized by a appearance toward market concentration, with a handful of prominent companies wielding significant power. These sector giants, often bolstered by established distribution networks and strong brand recognition, present a difficult picture for competition and accessible hea

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces rising concerns about monopolies. A few dominant companies control a significant portion of the market, potentially restricting competition and driving up prices for consumers. This concern raises questions about the long-term impact on patient access to a